Friedland's Corner

top of page

FC Global Strategies.png

Strategists and Implementers
for growing companies globally

Subscribe to Our Newsletters

Disclaimer & DIsclosure

Recent Postings

MedNews: Retension Pharmaceuticals raises $10.4 million to fund clinical trials for patients suffering from resistant and uncontrolled hypertension

Aug 22, 20243 min read

MedNews: Retension Pharmaceuticals raises $10.4 million to fund clinical trials for patients suffering from resistant and uncontrolled hypertension

Retension Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing RTN-001 as a therapy for patients with hypertension.

bottom of page